|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
73,290 |
|
Indirect Shares
|
882 |
|
|
Direct
Value |
$27,217,333 |
|
|
Indirect Value
|
$419,021 |
|
|
Total
Shares |
74,172 |
|
|
Total
Value |
$27,636,354 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-06-05 |
57,290 |
2024-06-05 |
882 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-03-29 |
4 |
OE |
$37.86 |
$3,576,273 |
D/D |
80,500 |
179,835 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-06-01 |
4 |
OE |
$51.75 |
$1,578,375 |
D/D |
30,500 |
129,835 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-09-30 |
4 |
OE |
$33.28 |
$3,244,925 |
D/D |
86,000 |
124,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-19 |
4 |
OE |
$77.31 |
$1,546,200 |
D/D |
20,000 |
119,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-02-03 |
4 |
A |
$0.00 |
$58 |
D/D |
20,923 |
107,019 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-18 |
4 |
OE |
$39.05 |
$508,748 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-20 |
4 |
OE |
$45.11 |
$546,649 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-02-13 |
4 |
AS |
$87.68 |
$673,733 |
D/D |
(7,684) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-03-29 |
4 |
AS |
$106.30 |
$8,664,568 |
D/D |
(80,500) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-05-15 |
4 |
AS |
$114.37 |
$13,267 |
D/D |
(116) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-06-01 |
4 |
AS |
$125.00 |
$3,812,500 |
D/D |
(30,500) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-19 |
4 |
AS |
$161.00 |
$3,220,000 |
D/D |
(20,000) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-02-02 |
4 |
A |
$0.01 |
$173 |
D/D |
17,299 |
96,262 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-02-03 |
4 |
A |
$0.01 |
$173 |
D/D |
17,250 |
95,921 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-05 |
4 |
OE |
$32.16 |
$2,041,329 |
D/D |
61,907 |
90,894 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-21 |
4 |
AS |
$158.05 |
$1,386,691 |
D/D |
(8,625) |
90,710 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-11-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-01-09 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-02-18 |
4 |
AS |
$112.62 |
$670,256 |
D/D |
(5,937) |
89,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-18 |
4 |
AS |
$130.00 |
$1,560,000 |
D/D |
(12,000) |
89,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-20 |
4 |
AS |
$135.08 |
$1,620,960 |
D/D |
(12,000) |
89,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-05-07 |
4 |
OE |
$29.25 |
$1,645,313 |
D/D |
56,250 |
89,858 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-02-03 |
4 |
AS |
$89.91 |
$923,460 |
D/D |
(10,166) |
86,096 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-05-16 |
4 |
AS |
$81.67 |
$9,555 |
D/D |
(117) |
86,096 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-11-15 |
4 |
AS |
$93.36 |
$10,830 |
D/D |
(116) |
86,096 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|